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ABSTRACT | The aim of this study was to investigate the 
relationship between the work in two exercise capacity 
tests, a maximum and a submaximal exercise, and the level 
of airflow obstruction in patients with Chronic Obstructive 
Pulmonary Disease (COPD). Fifty-three subjects with COPD 
(29 men, 70±9 years old, 65±14 kg, forced expiratory vol-
ume in the first second [FEV
1
] 38[31–54]% predicted) had 
their lung function assessed by spirometry, and maximal 
and submaximal exercise capacity were evaluated by the 
Incremental Shuttle Walking test (ISWT) and the 6-Minute 
Walk Test (6MWT), respectively. The work in the tests was 
calculated by multiplying the covered distance and the 
individual’s body weight (W). To evaluate the contribution 
of weight on the developed work, subjects were separated 
into two groups: higher weight (n=32), and lower weight 
(n=21). FEV
1
 correlated with the distance on the ISWT and 
with the ISWT*W (r=0.43 and r=0.49, respectively; p<0.05 
for both). Moreover, the distance on the ISWT correlated 
with the ISWT*W (r=0.88, p<0.0001). Regarding the 6MWT, 
it was observed that FEV
1
 had a weak correlation with the 
covered distance (r=0.29, p=0.03) and a moderate one with 
the 6MWT*W (r=0.51, p<0.0001). Moreover, the distance 
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covered in the 6MWT was moderately correlated with the 
6MWT*W (r=0.47, p=0.0004). The higher weight group 
showed worse performance only in the 6MWT compared 
to the lower weight group (407±85 versus 469±64 meters, 
respectively; p=0.004). The work on the used exercise tests 
was similarly related to the level of airflow obstruction. The 
submaximal test, however, appears to have its performance 
more influenced by the individuals’ body weight.
Keywords | Pulmonary Disease, Chronic Obstructive; 
Exercise Tolerance; Airway Obstruction.
RESUMO | Objetivou-se investigar a relação do trabalho 
desenvolvido em dois testes de capacidade de exercício, 
um máximo e outro submáximo, com o grau de obstru-
ção ao fluxo aéreo em indivíduos com Doença Pulmonar 
Obstrutiva Crônica (DPOC). 53 indivíduos com DPOC 
(29 homens, 70±9 anos, 65±14 kg, volume expiratório força-
do no primeiro segundo [VEF
1
] 38[31–54]% previsto) tiveram 
avaliadas sua função pulmonar, por meio de espirometria, e 
capacidade de exercício máxima, pelo Incremental Shuttle 
Walking Test (ISWT), e submáxima, pelo teste de caminhada 
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INTRODUCTION
Chronic Obstructive Pulmonary Disease (COPD) is 
characterized by limited airflow, usually progressive 
and associated with an abnormal inflammatory re-
sponse of the lungs to the inhaling of toxic particles 
and/or gases, especially the smoke from cigarretes1. 
Data from the World Health Organization (WHO) 
indicate that, in 2030, COPD can be the third major 
cause of death in the world2.
Even though COPD affects primarily the lungs, it 
also has significant systemic effects1. Individuals with 
COPD present relevant decrease in exercise capacity3, 
which happens especially due to ventilatory limitation, 
abnormalities in gas exchanges, cardiovascular limita-
tion, and respiratory and peripheral muscle dysfunc-
tion4. The assessment of exercise capacity in individu-
als with COPD is clinically important, since it allows 
to measure the severity of the disease5, the response to 
pharmacological and non-pharmacological interven-
tions6,7, and even preoperative risk8.
Several authors have found weak or no correlation 
between measures of pulmonary function and covered 
distance in exercise capacity tests among patients with 
COPD9-11. Some authors, however, defend that the cov-
ered distance in these tests may not be the best out-
come to be investigated, and that its product times body 
weight may have more clinical significance11,12. This new 
outcome has been described as the performance in tests, 
and it has been used to prescribe the intensity of train-
ing in pulmonary rehabilitation programs and to esti-
mate the maximal load in incremental tests13.
A few authors investigated the relationship between 
level of airflow obstruction with the work in exercise ca-
pacity tests, and none of them seems to have assessed and 
compared this relationship between maximal and submax-
imal tests. While Carter et al.14 and Chuang et al.12 found 
correlation between FEV1 and the work in the 6MWT, 
Teixeira et al.11 did not find any correlation. With regard 
to the Incremental Shuttle Walking Test (field test with 
incremental aspect), there are no studies that correlated the 
work in this test with the level of airflow obstruction.
de seis minutos (TC6min). O trabalho desenvolvido nos testes foi 
calculado pelo produto da distância percorrida com o peso corpo-
ral do indivíduo (P). Para avaliar a contribuição do peso no desem-
penho dos testes, os indivíduos foram separados em dois grupos: 
maior peso (n=32), e menor peso (n=21). Observou-se correlação do 
VEF
1
 com a distância percorrida no ISWT e com o ISWT*P (r=0,43 
e r=0,49, respectivamente; p<0,05 para ambas). Além disso, a dis-
tância percorrida no ISWT correlacionou-se com o ISWT*P (r=0,88; 
p<0,0001). Em relação ao TC6min, observou-se que o VEF
1
 apre-
sentou correlação fraca com a distância percorrida (r=0,29; p=0,03) 
e moderada com o TC6min*P (r=0,51; p<0,0001). Além disso, a dis-
tância percorrida no TC6min correlacionou-se moderadamente 
com o TC6min*P (r=0,47; p=0,0004). O grupo maior peso apresen-
tou pior desempenho somente no TC6min comparado ao menor 
peso (407±85 versus 469±64 metros, respectivamente; p=0,004). 
O trabalho desenvolvido nos testes utilizados relacionou-se com o 
grau de obstrução ao fluxo aéreo de forma semelhante nos dois 
testes. O teste submáximo, contudo, teve seu desempenho mais 
influenciado pelo peso corporal dos indivíduos.
Descritores | Doença Pulmonar Obstrutiva Crônica; Tolerância 
ao Exercício; Obstrução das Vias Respiratórias.
RESUMEn  |  Este estudio tuvo como objetivo investigar la relación 
de labor desarrollada en dos tests de capacidad de ejercicio, un 
máximo y otro submáximo, con el grado de obstrucción del flujo 
aéreo en individuos con Enfermedad Pulmonar Obstructiva Crónica 
(EPOC). Los 53 individuos con EPOC (29 hombres, 70±9Años, 
65±14kg, volumen espiratorio forzado en el primer segundo [VEF1] 
38 [31-54]% previsto) tuvieron evaluadas su función pulmonar, a 
través de espirometría, y capacidad máxima de ejercicio en por el 
Incremental Shuttle Walking Test (ISWT), y submáxima, por el test 
de caminata de seis minutos (TC6min). El trabajo desarrollado en 
los tests fue calculado por el producto de la distancia recorrida con 
el peso corporal del individuo (P). Para evaluar la contribución del 
peso en el rendimiento de los tests, los individuos fueron separados 
en dos grupos : de alto peso (n=32) y bajo peso (n=21). Se obser-
vó una correlación del  VEF1 con la distancia recorrida en el ISWT 
y con el ISWT*P (r=0,43 y r=0,49, respectivamente; P<0,05 para am-
bos). Además, la distancia recorrida en ISWT se correlacionó con 
el ISWT*P (r=0,88;P<0,0001). En cuanto al TC6min, se observó que 
el VEF1 presentó una correlación débil con la distancia recorrida 
(r=0,29; P=0,03) y moderada a TC6min*P (r=0,51; P<0,0001). Aparte, 
la distancia recorrida en la TC6min se correlacionó moderada-
mente  con el TC6min*P (r=0,47; P=0,0004). El grupo de alto peso 
mostró peor desempeño solamente en el TC6min en comparación 
con el de bajo peso (407±85 vs. 469±64 metros, respectivamente; 
P=0,004). El trabajo en los tests utilizados se relacionó con el grado 
de obstrucción  del flujo de aire de manera similar en ambos los 
tests. El test submáximo, sin embargo, tuvo su rendimiento más in-
fluenciado por el peso corporal de los individuos. 
Palabras clave | Enfermedad Pulmonar Obstructiva Crónica; 
Tolerancia al Ejercicio; Obstrucción Respiratoria..
83
Oliveira et al. Work in two exercise tests in COPD
Therefore, the objective of this study was to in-
vestigate the relationship between the work in two 
exercise capacity tests, a maximal and a submaximal 
one, with the level of airflow obstruction in individu-
als with COPD.
METHODOLOGY
Study design and subjects
Individuals were recruited in the initial assess-
ment to participate in pulmonary rehabilitation 
programs. The study was approved by the Ethics 
Committee, and individuals responded to the in-
formed consent form.
Inclusion criteria were: diagnosis of COPD — 
according to the criteria from the Global Initiative 
for Chronic Obstructive Lung Disease (GOLD)1 — 
absence of exacerbations/respiratory infections for at 
least three months before the beginning of the study; 
absence of severe and/or impairing comorbidities, 
which might interfere in the performance of 
evaluations and; not having followed any exercise 
program in the past year. Individuals were excluded 
in case they did not demonstrate physical and/or 
cognitive conditions to perform the tests, or in case 
they gave up participating in the study for any reason. 
Procedures
•	 Pulmonary function: Simple spirometry was con-
ducted (SpiroBank G, MIR, Italy). The technique 
was in accordance with international standardi-
zation15. Measures were obtained after the use of 
bronchodilator medications (400 mcg of salbuta-
mol), and individuals were classified according to 
GOLD1. Reference values for the Brazilian popu-
lation were used16.
•	 Maximal exercise capacity: The Incremental Shuttle 
Walking Test (ISWT)17 was used, in its modified ver-
sion18, to assess the maximal exercise capacity. Reference 
values were the ones described by Probst et al.19.
•	 Submaximal exercise capacity: It was assessed by the 
6 Minute Walking Test (6MWT), conducted ac-
cording to the guidelines of the American Thoracic 
Society (ATS)19. The reference values of Troosters 
et al.20 were used.
The exercise capacity tests were used on different 
days, and each of them was repeated twice, with min-
imum interval of thirty minutes between them. The 
largest covered distance was considered for analysis. 
The work in each test was calculated by the product of 
the distance times the individual’s body weight (dis-
tance in kilometers x weight in kilograms)12. This for-
mula comes from the calculation of work in a horizon-
tal surface on a treadmill: K.m.V∙T∙cosθ12, in which 
“K” is the performance coefficient, “m” is body weight, 
“V” is velocity, and “T” is walking time. Inclination 
is null and “K” and “T” are constant. Therefore, the 
formula changes into velocity (V) — which may be 
considered as a performance measure and replaced by 
distance — multiplied by weight (m)12.
In order to assess the contribution of body weight 
on the performance during tests, individuals were sep-
arated in 2 groups: higher weight and lower weight 
(above or below, respectively, the mean body weight of 
the total sample).
Statistical analysis
Sampling calculation was based on the study by Carter 
et al.14, who found a correlation coefficient between 
FEV1 and performance in 6MWT of 0.52. By using 
the software BioEstat® 3.0 (Belém, Brazil), with 85% 
power and 0.01 alpha, added by 20% of loss, 53 subjects 
would be necessary to detect statistically significant 
correlation. 
The Shapiro-Wilk test was used to verify data 
distribution. For the comparison between groups, 
the non-paired Student t-test — or the One-Way 
ANOVA (post hoc Tukey) —, and the Mann-Whitney 
test were used — or Kruskal Wallis (post hoc Dunn). 
For correlations, the Pearson or Spearman correlation 
coefficient was used. The adopted significance level was 
p<0,05, and the used software was GraphPad Prism 5 
(GraphPad Software Inc., La Jolla, California, USA).
RESULTS
The characteristics of the 53 patients are in Table 1. 
In the comparison between groups, there was difference 
only in variables of pulmonary function, as expected. 
The absolute value of covered distance, in the percent-
age of the predicted value, and the performance in the 
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analysis of ISWT*P between groups classified by 
GOLD, it was observed that the group GOLD II 
(28.7[23.0–41.3] km·kg) presented more work than 
groups GOLD III and GOLD IV (21.5[14.7–27.3] 
km·kg and 15.3[13.8–21.7] km·kg, respectively; 
p<0,05). The same happened when compared to the 
covered distance in ISWT (p<0.05).
In the same analyses for the 6MWT, FEV1 was 
positively and weakly correlated with the covered 
distance in the test (r=0.29; p=0.03), and positive-
ly and moderately correlated with the 6MWT*P 
(r=0.51; p<0.0001). A moderate correlation was also 
found between the covered distance in the 6MWT 
and the 6MWT*P (Figure 2). There was no differ-
ence in the comparison between the covered distance 
in groups (GOLD II: 475±63 m versus GOLD III: 
437±87  m versus GOLD IV: 404±63  m, p>0.05). 
However, there were differences in the comparison 
of the 6MWT*P, since group GOLD II presented 
higher value than GOLD IV (31.5±6.3 km·kg ver-
sus 23.7±4.6 km·kg, respectively; p<0.05).
There was no statistical difference in the compari-
son between covered distance in the ISWT among 
higher weight (n=21) and lower weight (n=32) 
groups (i.e., above or below sampling mean, respec-
tively). However, in the 6MWT, the higher weight 
group covered a shorter distance (Figure 3). It was 
also observed that there was no statistical difference 
in the comparison of FEV1 between groups (predict-
ed lower weight: 37[31–52]% versus predicted higher 
weight: 42[31–60]%; p=0.27).
Figure 3. Comparison between covered distance and higher and lower 
weight groups in the Incremental Shuttle Walking Test and the 6 Minute 
Walking Test
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Figure 1. Correlation between covered distance and maximal work 
developed in the Incremental Shuttle Walking Test 
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Figure 2. Correlation between covered distance and maximal work 
performed in the 6 Minute Walking Test
ISWT in the total sample were of 382±145 m, 60±21% 
of the predicted value and 23.2[15.8–29.5] km·kg, 
respectively. The values for the same outcomes in the 
6MWT were 445±79 m, 75±13% of the predicted value 
and 28.1[24.3–33.5] km·kg, respectively.
There was correlation between FEV1 and cov-
ered distance (r=0.43; p=0.001) and performance 
(r=0.49; p=0.0002) in the ISWT (Figure 1). In the 
Table 1. General characteristics of individuals included in this study
Characteristic
Total 
sample
GOLD II GOLD III GOLD IV
n (M/W) 53 (29/24) 18 (8/10) 26 (15/11) 9 (6/3)
Age (years) 70±9 64±9 69±9 66±7
Weight (kg) 66±14 67 [57–80] 61 [57–73] 55 [46–76]
Height (m) 1,61±0.08 1.59±0.09 1.62±0.08 1,61±0,08
BMI (kg/m2) 26±6 27 [22–31] 24 [21–29] 20 [18–30]
FEV
1
 (% prev) 38 [31–54] 60 [53–66] 37 [34–42]* 26 [22–27]*,†
FVC (% prev) 66±14 76 [69–83] 60 [55–70]* 62 [41–74]*
FEV
1
/FVC (%) 64±16 78±9 61±12* 45±12*,†
Data expressed in absolute frequency, mean ± standard deviation or median [interquartile 
interval]; M: men; W: women; BMI: Body Mass Index; FEV
1
: Forced Expiratory Volume in the first 
second; FVC: Forced Vital Capacity; GOLD: Global Initiative for Chronic Obstructive Lung Disease; 
*p<0.05 versus GOLD II; †p<0.05 versus GOLD III
ISWT: Incremental Shuttle Walking Test
6MWT: six minutes walking test
ISWT: Incremental Shuttle Walking Test; 6MWT: six minutes walking test
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DISCUSSION
In this study, it was observed that the work performed 
in maximal and submaximal exercise capacity tests was 
similarly correlated with the level of airflow obstruction 
in individuals with COPD. When the relationship be-
tween this last variable and the distance covered in tests 
was analyzed, however, a lower value was observed in 
the submaximal test. Besides, a weaker correlation was 
noticed between distance and the work performed in 
this test. Finally, it was possible to observe that heavier 
individuals presented with worse submaximal exercise 
capacity, but not maximal, in relation to those with 
lower weight. 
Several authors investigated the relationship be-
tween pulmonary function and distance covered in the 
6MWT and in the ISWT9,10, however, only a few in-
vestigated the relationship with the work performed 
in these tests. Pitta et al.10 did not find any significant 
correlation between distance covered in the 6MWT 
and FEV1. Fink et al.9 also demonstrated that airflow 
obstruction is not correlated with exercise capacity in 
patients with COPD. Other authors even found statis-
tically significant correlations, however, weak ones21-23. 
In this study, FEV1 was correlated with the distance 
covered in both tests, however, a stronger correlation, 
even if modest, was verified with the ISWT.
According to Chuang et al.12, work is defined as the 
necessary energy to transport the weight of the body, 
through specific distance and in a certain period of time. 
In this study, the work performed in the 6MWT was 
assessed, and a 0.36 correlation coefficient was found 
with FEV1 (P=0.06). Likewise, Carter et al.14 demon-
strated the correlation of pulmonary function variables, 
like FEV1, with the work performed in the 6MWT. 
Results in this study, as well as the ones in the analyses 
by Chuang et al.12 and Carter et al.14, showed higher 
correlation between FEV1 and the work performed in 
the 6MWT than with the covered distance. Besides, 
both authors found that walking presented more sen-
sitivity and specificity to predict the exercise capacity 
in patients with COPD24. Differently, Teixeira et al.11 
did not find a significant correlation between the level 
of airflow obstruction and the 6MWT*P, as well as in 
relation to the covered distance in this test. There are no 
studies correlating the work performed in the ISWT 
with pulmonary function variables. In this study, unlike 
the 6MWT, similar correlation coefficient values were 
found between FEV1 and the distance and the work 
performed in ISWT.
It is worth to mention that heavier individuals with 
COPD presented worse submaximal exercise capacity 
than lighter individuals; however, there was no difference 
in the comparison of maximal exercise capacity. Recently, 
it has been demonstrated that higher body weight (i.e., 
overweight and obesity) provides better mechanical 
advantage concerning hyperinsufflation25,26. However, 
this finding does not reflect on more exercise capacity. 
It is believed that due to differences in test protocols, the 
performance in the 6MWT is more prone to changes 
in heavier individuals than the performance in ISWT, 
because during the 6MWT people can decrease and 
adapt velocity to their conditions when feeling difficulties. 
This is not true for the ISWT, since the individual has no 
choice but to go according to a standardized velocity to 
complete the test.
It is known that the 6MWT can also work as a 
maximal test. According to Troosters et al.27, the oxy-
gen consumption (VO2) reached and maintained in the 
6MWT can be equivalent to the peak VO2 reached 
during the incremental test on the bicycle. However, by 
analyzing the test design, we observed it is a submaximal 
test. By considering the weight of the patient to find the 
real work required to conclude the test, we come closer 
to the person’s daily reality. On the other hand, when 
the objective is to assess the maximal exercise capacity 
of a patient, tests with standardized protocols, such as 
ISWT, are necessary.  
In spite of all efforts to perform this study, some 
limitations have occurred. No individual classified 
as GOLD I was included in the study, which might 
reduce the external validity of findings; however, it 
is known that most of these individuals are asymp-
tomatic, and that is why they do not seek medical 
care, which makes diagnosis more difficult and, con-
sequently, also the participation in studies. In order 
to assess exercise capacity, the gold standard test (i.e., 
cardiopulmonary exercise testing28) was not used due 
to the difficulty to access laboratories with specific 
devices. However, in ISWT, the test used to measure 
the maximal exercise capacity has been proven to be 
valid in relation to the gold standard4.
CONCLUSION
By means of this study, it is possible to conclude that 
the work performed in exercise capacity tests is cor-
related with the level of airflow obstruction similarly 
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between maximal and submaximal tests in individuals 
with COPD. The performance in submaximal tests, 
however seems to be more influenced by the body 
weight of individuals than the performance in the 
maximal test. However, further studies are necessary 
to prove this finding. 
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